Anas Younes Selected Research

Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)

11/2015	Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.
4/2014	Clinical roundtable monograph: CD30 in lymphoma: its role in biology, diagnostic testing, and targeted therapy.
3/2014	From empiric to mechanism-based therapy for peripheral T cell lymphoma.
7/2013	Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma.
5/2012	Brentuximab vedotin in systemic T-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anas Younes Research Topics

Disease

103	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2002
80	Neoplasms (Cancer) 10/2023 - 01/2002
74	Lymphoma (Lymphomas) 11/2023 - 12/2002
38	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 09/2003
28	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 11/2010
19	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2023 - 03/2003
17	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2023 - 12/2003
16	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 08/2003
12	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2016 - 12/2003
9	Neutropenia 10/2018 - 07/2005
8	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 02/2008
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2019 - 10/2004
6	Disease Progression 10/2018 - 03/2004
6	Infections 12/2017 - 04/2005
6	Necrosis 03/2011 - 08/2003
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2015 - 05/2012
4	Febrile Neutropenia 12/2020 - 07/2005
4	Thrombocytopenia (Thrombopenia) 01/2018 - 11/2010
4	Leukemia 02/2012 - 10/2004
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2019 - 08/2008
3	Anemia 08/2017 - 07/2005
3	Multiple Myeloma 08/2017 - 03/2004
3	Nausea 08/2017 - 03/2015
2	Exanthema (Rash) 01/2022 - 02/2019
2	Hypertension (High Blood Pressure) 01/2022 - 08/2017

Drug/Important Bio-Agent (IBA)

35	Rituximab (Mabthera)FDA Link 01/2023 - 07/2003
31	Brentuximab VedotinIBA 01/2022 - 11/2010
25	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2004
18	Monoclonal AntibodiesIBA 01/2023 - 03/2003
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 12/2004
13	ibrutinibIBA 01/2022 - 08/2014
12	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 12/2004
11	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 11/2006
11	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 11/2006
10	Prednisone (Sone)FDA LinkGeneric 01/2023 - 12/2004
10	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 11/2006
10	PanobinostatIBA 11/2018 - 09/2010
10	Histone Deacetylase InhibitorsIBA 11/2018 - 11/2009
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2012
9	LigandsIBA 10/2018 - 09/2003
9	Immunoconjugates (Immunoconjugate)IBA 01/2018 - 01/2007
8	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 04/2005
8	CytokinesIBA 05/2014 - 08/2003
7	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2002
7	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 12/2003
7	Bortezomib (Velcade)FDA Link 01/2018 - 05/2004
7	fludarabineIBA 01/2016 - 12/2002
6	mocetinostatIBA 01/2023 - 09/2010
6	NivolumabIBA 01/2021 - 01/2016
6	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 04/2005
5	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 10/2013
5	Phosphotransferases (Kinase)IBA 01/2023 - 08/2004
5	AntigensIBA 01/2020 - 01/2007
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2019 - 11/2009
5	AntibodiesIBA 01/2016 - 08/2005
5	Vorinostat FDA Link 07/2013 - 04/2008
5	tanespimycin (17AAG)IBA 05/2012 - 04/2005
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2007 - 04/2005
4	B7-H1 AntigenIBA 01/2023 - 02/2016
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 08/2014
4	EnzymesIBA 11/2017 - 11/2009
4	Melphalan (Alkeran)FDA LinkGeneric 01/2016 - 04/2005
4	Gemcitabine FDA Link 01/2016 - 02/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2008 - 08/2003
4	NF-kappa B (NF-kB)IBA 03/2007 - 01/2002
3	GalliumIBA 11/2023 - 06/2007
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2020
3	Bendamustine Hydrochloride FDA Link 12/2022 - 08/2017
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021 - 08/2003
3	Pentostatin (Nipent)FDA LinkGeneric 01/2019 - 09/2003
3	Antisense OligonucleotidesIBA 11/2018 - 11/2008
3	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 03/2015
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018 - 02/2006
3	CUDC-907IBA 11/2017 - 01/2016
3	entinostat (MS 275)IBA 01/2016 - 09/2010
3	Protein Isoforms (Isoforms)IBA 01/2016 - 10/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 03/2006
3	InterferonsIBA 05/2012 - 07/2005
3	MTOR InhibitorsIBA 04/2012 - 07/2008
3	temsirolimus FDA Link 11/2010 - 04/2008
3	TOR Serine-Threonine KinasesIBA 11/2010 - 04/2008
3	Proteasome InhibitorsIBA 11/2010 - 05/2004
3	galiximabIBA 01/2007 - 03/2003
2	Heme (Haem)IBA 10/2023 - 12/2018
2	Lenalidomide (CC 5013)FDA Link 08/2023 - 07/2012
2	venetoclaxIBA 01/2023 - 01/2021
2	atezolizumabIBA 01/2023 - 10/2022
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 06/2003
2	NVP-BKM120IBA 01/2022 - 12/2017

Therapy/Procedure

77	Therapeutics 08/2023 - 12/2002
42	Drug Therapy (Chemotherapy) 10/2021 - 03/2002
23	Stem Cell Transplantation 01/2018 - 12/2002
8	Radiotherapy 10/2022 - 03/2002
5	Combination Drug Therapy (Combination Chemotherapy) 07/2016 - 09/2003
4	Immunotherapy 01/2021 - 02/2008
4	Aftercare (After-Treatment) 12/2013 - 07/2005
3	Drug Tapering 12/2020 - 05/2012
3	Precision Medicine 11/2019 - 10/2014
3	Salvage Therapy 01/2018 - 11/2014